Dementia and Movement Disorders Market - Global Industry Analysis

Dementia and Movement Disorders Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Category: Healthcare Report Format : PDF Report Code: ZMR-3009 Status : Upcoming

Description

Global Dementia and Movement Disorders Market: Overview

Dementia is mainly recognized as mental illnesses, which can lead to degeneration of the capability to remember or think in an individual. As a result, the syndrome is only treated symptomatically. However, in several cases movement disorders are also observed, for instance, Parkinson’s are recognized to be a medium for dementia. Based on the research around 80% of individuals with Parkinson’s or other movement syndromes are likely to develop cognitive issues.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Dementia and Movement Disorders Market: Growth Factors

Global dementia and movement disorders market is driven by a quickly expanding geriatric populace highly susceptible to different neurodegenerative syndromes. In addition to this, other major aspects which are slated to optimistically impact the market are a frequent partnership among pharmaceutical companies, research organizations, drug and device manufacturing firms, and medical institutes. These collaborations have resulted in tremendous R&D efforts aimed at the discovery of effective treatment options for the condition of dementia & movement disorders.

The global market is, however, affected by many restraints that threaten to obstruct its expansion in the coming years. A key restraining aspect is a limited knowledge regarding brain mechanisms as well as the various neurodegenerative syndromes. Furthermore, management solutions for neurological disorders, the absence of comprehensive therapeutics, drug failures in late-stage clinical trials, lengthy approval time for drugs, rigid regulatory requirements and devices act as deterrents to the development of the market for global dementia and movement disorders market.

Global Dementia and Movement Disorders Market: Segmentation

Global dementia and movement disorders market can be classified in terms of drugs utilized for movement disorders & progressive dementia with other neurological abnormalities and treatment of progressive dementia. Amongst these, the division of drugs majorly used in the treatment of progressive dementia is categorized as diseases based therapeutics in progressive dementia and drugs for progressive dementia. Furthermore, the division of drugs utilized with other different neurological abnormalities to treat progressive dementia is fragmented into disease-based therapeutics with other neurological abnormalities and drugs with other neurological abnormalities for progressive dementia under progressive dementia. Also, the division of drugs utilized for treating movement disorders is divided into diseases based therapeutics and drugs for movement disorders in movement disorders.

Global Dementia and Movement Disorders Market: Regional Analysis

North America is likely to account for a momentous share in the global market, driven mainly by the high occurrence rate of the neurodegenerative syndrome, also resulting in a large number of individuals living with limited mobility. With considerably aging inhabitants, the number of individuals afflicted by different neurological syndromes has augmented. The market for dementia and movement disorders in Europe is likely to be the strong contender in the overall development and is likely to be propelled by similar aspects.

The Asia Pacific is projected to register significant expansion rate in the coming future with a growing number of responsiveness programs particularly initiated by private as well as public healthcare institutions. A huge population base, which includes geriatrics and increasing healthcare insurance coverage is likely to be responsible for the anticipated expansion of the Asia Pacific region for global dementia and movement disorders market.

Global Dementia and Movement Disorders Market: Competitive Players

Some of the most important market players in the global dementia and movement disorders market are Valeant Pharmaceutical International, Pfizer, Hoffmann-La Roche, Novartis AG, AstraZeneca GmbH, Sanofi S.A., and Merck & Co., among others.

Global Dementia and Movement Disorders Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed